Atovaquone Suspension
Product Images NDC 65162-693

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 65162-693). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Atovaquone Oral Suspension 1)

Chemical structure of atovaquone, the active ingredient in the product ATOVAQUONE 750 mg/5mL oral suspension by Amneal Pharmaceuticals LLC.*

FDA Label Image

Carton (Atovaquone Oral Suspension 2)

Label for ATOVAQUONE Oral Suspension USP, 750 mg/5 mL, distributed by Amneal Pharmaceuticals LLC. The label includes storage instructions to keep between 15° to 25°C, avoid freezing, and advises shaking gently before use. The net contents are 210 mL. The label states Rx only and includes a barcode and space for lot and expiration dates.*

FDA Label Image

Label (Atovaquone Oral Suspension 3)

This is the packaging label for ATOVAQUONE Oral Suspension, USP 750 mg/5 mL, an oral liquid formulation by Amneal Pharmaceuticals LLC. The label includes the active ingredient strength, directions to see the package insert for dosage, storage instructions, and warnings. The container holds 210 mL and includes barcodes and branding.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.